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Abstract An infant w ith  severe deficiency of complex III 
combined with less severe deficiencies o f complexes I, II 
and IV of the m itochondrial respiratory chain in skeletal 
muscle tissue presented with intra-uterine growth re tar­
dation, generalized hypo ton ia  and delayed m otor de­
velopment. In the following 3.5 years muscle tone and 
m otor development gradually  normalized whereas the 
lactic acidosis and enzyme activities did not improve.
Conclusion This favourablerepo rt  documents a 
clinical course in a  child with combined respiratory 
chain deficiency despite persistent biochemical abnor­
malities.
Key words M itochondria  • Combined deficiency 
Abbreviation R C  respiratory chain
Introduction
The clinical presentation o f  patients with isolated or 
com bined defects in th e  respiratory chain (RC) is vari­
able. N eonata l or early infant m anifestations usually 
predict a  severe clinical course. A  m ore benign course 
has rarely been reported. Five patients have been re­
ported  with a benign complex IV deficiency; in all of 
them, the enzyme activity norm alized at the time of 
clinical im provem ent [2 , 6, 7, 10, 11], O ne report de­
scribes a benign complex I deficiency, bu t there are no 
da ta  available regarding enzyme activity after clinical 
im provem ent [9]. Here we describe an  infant with per­
sistent severe deficiency of complex III combined with 
less severe deficiencies of complexes I, II and IV and a 
favourable clinical course.
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Case report
This 1.7 kg ( < 3 r d  percentile) infant was born  after 38 weeks ges­
tation and had Apgar scores of 9 and 10 a t 1 and 5 min, respec­
tively. Length was 41 cm ( < 3rd percentile). The umbilical pH  was 
7,34. She was the third child of unrelated healthy parents. Two 
older siblings are healthy. The m other had two miscarriages.
Physical examination at birth revealed no abnormalities except 
for generalized hypotonia. During the first 5 weeks of life tube 
feeding became necessary because o f  diminished sucking.
A t 4 months o f  age she was readmitted to hospital because of 
failure to thrive. Physical examination showed a lively infant with a 
weight of 3840 g (percentile < 10), length 54 cm (percen­
tile < 10), head circumference 39.8 cm (percentile 10). Axial hy­
potonia, mild hypertonia o f  the limbs, and atrophy of shoulder, 
arm  and leg muscles were observed. The sucking reflex was m od­
erately active and  there were generalized stretch responses. No 
other abnormalities were noted.
Repeated blood analysis showed increased lactate concentra­
tions (3-10 mmol/1; N  < 2.1), increased lactate to pyruvate ratios 
(40-60; N  10-15), elevated concentrations of 3-OH-butyrate (0.18-
1.60 mmol/1; N  0.02-0.09) and acetoacetate (0.06-0.34 mmol/1; N
0.016-0.040) and elevated 3-OH-butyrate to acetoacetate ratios 
(2.8-4.7; N  < 2). Postprandial ketosis was present. Blood gas 
analyses showed a normal pH, C 0 2, and base excess and slightly 
decreased bicarbonate (20 mmol/1). Lactate concentration in CSF 
was 5.3 mmol/1 (N  < 2.1). Urine organic acid profile showed an
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increased concentration of lactate (3.0 mmol/mmol creatinine 
N < 0.1) and increased concentration of 3-OH-butyric acid 
(0.22 mmol/mmol creatinine N < 0.06). Creatinine, urea and 
transaminases were normal. Plasma alpha-tocopherol (9.5 j.imoI/1; 
N 15.6-43.8) and beta-carotene (< 0 .01  ¡.imol/1; N  0.10-0.80) con­
centrations at the age o f  3 m onths were reduced but normalized 
after supplementation. Electroencephalography and magnetic res­
onance imaging o f  the brain showed no abnormalities.
A defect in the R C  was suspected and a biopsy of the vastus 
lateralis muscle was performed at the age of 4.5 months.
The clinical course was characterized by refusal to eat necessi­
tating tube feeding. After her 3rd birthday her eating progressively 
improved and tube feeding was stopped. Her growth remained 
below but paralleled the 10th percentile curve despite adequate 
caloric intake and no signs o f  malabsorption. Despite persistent 
increased lactate concentrations in blood, the axial hypotonia and 
mild hypertonia of the limbs normalized in the 1st year. Her motor 
development was initially delayed (she sat unaided a t the age of 
1 year and walked at the age of 22 months) but normalized here­
after. Her m otor development according to the Hoskins-Squires 
scale [4] at 3.8 years was 3 years. The quality of the movements at 
this age was appropiate. T runk  tone was lower than normal. 
However, the tone elsewhere was normal. Assessment of motor 
development at 4.5 years was age adequate. There was never ex­
ercise intolerance. Psychological assessment according to the Mc­
Carthy Scale o f  Childrens Abilities [5] at age o f  3.9 years revealed a 
score of 68 (2 SD under average), at age 4.6 years the score had 
improved to 80 (more than 1 SD under average) with a homoge­
neous test profile on both occasions.
Methods
Surgical biopsies of the vastus lateralis muscle were performed, 
with informed parental consent, at age 4 months and age 3 years 
8 months. Light microscopy, histochemical and enzyme-hislo- 
chemical stainings were performed according to conventional 
procedures. Substrate oxidation rates, ATP production rates and 
mitochondrial enzyme activities in fresh muscle were measured in 
600 g  supernatants of muscle homogenates as described by Fischer
et al. [3] and Sperl et al. [8], Complex III was measured using 
decylubiquinol and horse cytochrome c as electron donor and ac­
ceptor, respectively. Tween 20 (0.04%) was added to abolish the 
non-enzymatic reaction and to break the mitochondria (Bentlage, 
unpublished results).
In order to search for the molecular cause of the disorder, total 
cellular DNA was isolated from muscle tissue as previously de­
scribed by De Vries et al, [1], Using restriction digestion of PCR- 
generated fragments of mitochondrial DNA, the DNA of the pa­
tient was tested for pathogenic mutations. Southern blot analysis 
was used to search for mitochondrial D N A  deletions. PvuII-di- 
gested DNA was separated on a 0.8% agarose gel and subsequently 
blotted to a nylon membrane. Hybridization with 32P-labeiled 
complete human mitochondrial DNA followed. Next, the gene for 
cytochrome h was sequenced using the dye terminator cyclese- 
quencing kit and the ABIA370 automated sequencer (Perkin Elmer),
Results
Examination of the first vastus lateralis muscle specimen 
showed normally distributed type I and type II fibres. 
Histochemical staining for oxidative enzymes and gly­
cogen gave normal results, but fibres contained large fat 
deposits. Electron microscopy showed enlarged abnor­
mal mitochondria with concentric cristae. Examination 
of the second vastus lateralis muscle specimen showed a 
high percentage of unequally distributed type I fibres (70 
versus 50 normally). Muscle fibres still showed signs of 
delayed maturation at this age, but diameters were 
normal. There were no fibres with internal nuclei, and 
succinate dehydrogenase and cytochrome c oxidase 
stains were normal. Electron microscopy demonstrated 
abnormal mitochondria with too few cristae, degenerat­
ing mitochondria, and mitochondria with dense deposits 
suggestive for early crystalloid formation (Fig. 1).
Fig. 1A-D Abnorm al m ito­
chondria in vastus lateralis 
muscle. (A) many mitochondria 
with dense deposits (B) m agni­
fication of a m itochondrion in 
A (C) mitochondria with too 
few cristae (D) a degenerating 
mitochondrion. Arrows in A , B , 
and D point to dense deposits 
representing early crystalloid 
formation. Bars: 0.5 \im (black) 
and 0.1 \im (white)
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Table 1 Biochemical parameters 
of vastus lateralis muscle tissue 1st biopsy 
age 4 months
(% )e 2nd biopsy (% )e 
age 3*5/ 12 years
Control
range
N
Oxidation rates1 for
[1“14C] Pyruvate + malate 0.57 (16) 0,47 (13) 3.61--7.48 14
[U-14C]Malate + pyruvate 0.45 (10) 0.52 (11) 4.68'-9.62 14
+ maionate
ATP + creatine phosphateproduction rates from
Pyruvate + malate 4.25 (10) 4.76 (ID 42.1--81.2 14
Succinate + acetylcarnitine n.d. n.d. 7.2- 18.4 14
Activity of
NADH:Qi oxidoreductased 0.050 (52) 0.017 (18) 0.096-0.197 13
Succinate dehydrogenased 0.050 (75) 0.056 (84) 0.067-0.177 11
Succinate:cyt c oxidoreductased 0,11 (37) 0.11 (37) 0.30--0.97 38
Decylubiquinol: n.d. 0.31 (11) 2.85--6.71 22
cyt c oxidoreductased
Cytochrome c oxidased 0.74 (91) 0.53 (65) 0.81--3.12 21
Pyruvate DH complexd 0.045 (136) 0.041 (124) 0.033-0.122 25
Citrate synthasec 124 (258) 78 (162) 48-162 32
il nanomole substrate oxidized per hour per milliunits citrate synthase 
b nanomole product formed per hour per milliunits citrate synthase 
c milliunits per milligram protein 
d milliunits per milliunits citrate synthase 
e Percentage of lowest control
n.d. not detectable
The oxidation rates with pyruvate and malate as 
substrates and ATP + creatine phosphate production 
rates from these substrates were severely decreased 
(Table 1). The activity of rotenone-sensitive NADH: 
ubiquinone oxidoreductase (complex I) was diminished 
(52% and 18% of the lowest control value in the first 
and second biopsy, respectively). Succinate dehydroge­
nase (complex II) activity was 75% and 84% of the 
lowest control value, in the first and second biopsy res­
pectively. Succinatexytochrome c oxidoreductase (com­
plex II + CoQ + complex III) was diminished (37% of 
the lowest control value in both biopsies). The decylu- 
biquinolxytochrom e c oxidoreductase (complex III) 
activity was undetectably low in the first biopsy and 
11% of the lowest control value in the second biopsy. 
Cytochrome c oxidase (complex IV) was diminished 
(91% and 65% of the lowest control value in the first 
and second biopsy respectively). Pyruvate dehydroge­
nase complex (PDHC) was normal in both biopsies.
None of the tested pathogenic mutations: A3243G 
(MELAS), T3271C (MELAS), A4317G (MELAS), 
A8344G (M ER R F), T8993G/C (NARP/Leigh syn­
drome), were detected. A deletion in the mitochondrial 
D N A  of the patient was excluded. Hybridization with 
32P-labelled complete hum an mitochondrial D N A  re­
vealed a single band of 16.5 kb representing the full- 
length linearized mitochondrial DNA, Cytochrome b 
sequencing showed one base substitution, G15043A, 
which does not change the aminoacid composition of the 
cytochrome b polypeptide.
diminished sucking. There were no obvious signs o f CNS 
involvement. As an infant she was flaccid but alert and 
responsive, in contrast to the lethargy associated with 
encephalopathy. Her m o to r  developm ent was delayed at 
first bu t normalized; o ther developm ental aspects were 
adequate. There were no clinical signs of encephalopa­
thy, M R I o f  the brain and  electroencephalography a t  the 
age o f 4.5 months, 2 and  4 years, showed no ab n o r­
malities. The lactate concentra tion  in CSF was elevated 
but this may only reflect the high concentration in b lood 
rather than CNS involvement. Biochemical studies in 
skeletal muscle showed a severe complex III deficiency 
combined with less severe deficiencies o f  complexes I, II 
and IV. A second biopsy specimen taken  at a time when 
she was free o f symptoms showed identical abnorm ali­
ties. Molecular studies showed one base substitution in 
cytochrome b , which does n o t change the aminoacid 
composition o f  the cytochrom e b  polypeptide and 
therefore reflects a silent polym orphism .
This case illustrates tha t a  severe deficiency of enzyme 
complexes of the respiratory chain in muscle, with sig­
nificantly impaired overall substrate  oxidation and ATP 
production rates, can have a favourable clinical course. 
Persistent biochemical abnorm alities suggest that there 
are unknown adap ta tion  m echanism s in skeletal muscle. 
W hether or n o t a lpha-tocopherol and beta-carotene 
supplementation contributed to  the favourable outcom e 
remains unknown.
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Discussion
This girl presented in the neonatal period with intra­
uterine growth retardation, generalized hypotonia and
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